Intra- and extraneuronal metabolism of 5-hydroxytryptamine in the isolated saphenous vein of the dog
- PMID: 6709075
- DOI: 10.1007/BF00507055
Intra- and extraneuronal metabolism of 5-hydroxytryptamine in the isolated saphenous vein of the dog
Abstract
The uptake and metabolism of 3H-5-hydroxytryptamine (5-HT) in the isolated saphenous vein of the dog was studied, as well as the sensitivity to 5-HT and its termination of action (as determined by oil immersion experiments). After exposure of the vein to 0.23 mumol/1 5-HT for 30 min, about one half of the 5-HT removed was accumulated in the tissue, the other half appearing in the form of metabolites. Cocaine, chlorimipramine or denervation reduced the accumulation, but not the metabolism, of 5-HT; hydrocortisone reduced both accumulation and metabolism. Hydrocortisone plus cocaine (or phenoxybenzamine alone) caused a greater reduction of accumulation and metabolism than hydrocortisone or cocaine alone. Pargyline caused an increase in accumulation and virtually abolished metabolism; amezinium also abolished metabolism, but reduced accumulation (the same effects as caused by cocaine plus pargyline). Cocaine (12 mumol/l) caused supersensitivity to 5-HT and a prolongation of the half-time for relaxation in oil; hydrocortisone (40 mumol/l) had no effect on sensitivity, but prolonged somewhat the half-time for relaxation in oil, showing supra-additive effects with cocaine. 5-HT, taken up into adrenergic nerve terminals, was released by electrical stimulation; no appreciable reduction in fractional release occurred during repeated stimulations. Exposure to cocaine prior to incubation with 5-HT prevented the neuronal uptake of 5-HT. Compartmental analysis, done with the help of washout curves of strips pretreated with pargyline and loaded with 3H-5-HT, shows that 3H-5-HT distributed into 3 compartments plus a bound fraction.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Influence of MAO A and MAO B on the inactivation of noradrenaline in the saphenous vein of the dog.Naunyn Schmiedebergs Arch Pharmacol. 1985 Feb;328(4):401-6. doi: 10.1007/BF00692908. Naunyn Schmiedebergs Arch Pharmacol. 1985. PMID: 3921856
-
Accumulation and release of [3H]-5-hydroxytryptamine in saphenous veins and cerebral arteries of the dog.J Pharmacol Exp Ther. 1983 Aug;226(2):579-88. J Pharmacol Exp Ther. 1983. PMID: 6875866
-
Structural and functional alterations caused at the extraneuronal level by sympathetic denervation of blood vessels.Naunyn Schmiedebergs Arch Pharmacol. 1984 Jul;326(4):302-12. doi: 10.1007/BF00501434. Naunyn Schmiedebergs Arch Pharmacol. 1984. PMID: 6482981
-
Release and disposition of 3H-noradrenaline in the saphenous vein of neonate and adult dogs.Naunyn Schmiedebergs Arch Pharmacol. 1993 Feb;347(2):186-91. doi: 10.1007/BF00169265. Naunyn Schmiedebergs Arch Pharmacol. 1993. PMID: 8474538
-
The kinetic characteristics of the extraneuronal Q-methylating system of the dog saphenous vein and the supersensitivity to catecholamines caused by its inhibition.Naunyn Schmiedebergs Arch Pharmacol. 1984 Aug;327(1):48-55. doi: 10.1007/BF00504991. Naunyn Schmiedebergs Arch Pharmacol. 1984. PMID: 6493350
Cited by
-
5-Hydroxytryptamine4 receptors mediate relaxation of the rat oesophageal tunica muscularis mucosae.Naunyn Schmiedebergs Arch Pharmacol. 1991 May;343(5):439-46. doi: 10.1007/BF00169544. Naunyn Schmiedebergs Arch Pharmacol. 1991. PMID: 1881455
-
The actions of 5-hydroxytryptamine receptor agonists and antagonists at pre- and postjunctional level on the canine saphenous vein.Naunyn Schmiedebergs Arch Pharmacol. 1988 Dec;338(6):616-22. doi: 10.1007/BF00165625. Naunyn Schmiedebergs Arch Pharmacol. 1988. PMID: 2977424
-
The effect of partial inhibition of monoamine oxidase on the steady-state rate of deamination of 3H-catecholamines in two metabolizing systems.Naunyn Schmiedebergs Arch Pharmacol. 1986 Jul;333(3):253-61. doi: 10.1007/BF00512938. Naunyn Schmiedebergs Arch Pharmacol. 1986. PMID: 3762740
-
Extraneuronal serotonin accumulation in peripheral arteries of the rat.Experientia. 1986 Dec 1;42(11-12):1244-5. doi: 10.1007/BF01946405. Experientia. 1986. PMID: 3096776
-
A 5-hydroxytryptamine receptor in human atrium.Br J Pharmacol. 1990 Aug;100(4):879-85. doi: 10.1111/j.1476-5381.1990.tb14108.x. Br J Pharmacol. 1990. PMID: 2169944 Free PMC article.